Real-time Estimate
Cboe BZX
12:44:30 2024-06-10 pm EDT
|
5-day change
|
1st Jan Change
|
46.88
USD
|
-0.47%
|
|
-1.17%
|
-30.46%
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
1,439
|
1,091
|
1,446
|
1,429
|
1,299
|
1,271
|
Enterprise Value (EV)
1 |
1,564
|
1,503
|
1,922
|
2,090
|
2,086
|
2,280
|
P/E ratio
|
14
x
|
15.5
x
|
16.7
x
|
16.7
x
|
10.6
x
|
10.8
x
|
Yield
|
5.21%
|
6.88%
|
5.22%
|
5.37%
|
5.97%
|
6.19%
|
Capitalization / Revenue
|
0.65
x
|
0.57
x
|
0.73
x
|
0.68
x
|
0.51
x
|
0.46
x
|
EV / Revenue
|
0.7
x
|
0.79
x
|
0.97
x
|
0.99
x
|
0.81
x
|
0.83
x
|
EV / EBITDA
|
7.13
x
|
8.34
x
|
8.83
x
|
9.27
x
|
8.75
x
|
8.03
x
|
EV / FCF
|
10.3
x
|
-91.1
x
|
20.1
x
|
-29.8
x
|
-30.2
x
|
-14.6
x
|
FCF Yield
|
9.67%
|
-1.1%
|
4.98%
|
-3.36%
|
-3.32%
|
-6.85%
|
Price to Book
|
1.08
x
|
0.87
x
|
1.11
x
|
1.06
x
|
0.93
x
|
0.88
x
|
Nbr of stocks (in thousands)
|
24,969
|
24,670
|
24,515
|
24,608
|
24,555
|
24,573
|
Reference price
2 |
57.63
|
44.21
|
58.99
|
58.07
|
52.89
|
51.72
|
Announcement Date
|
5/24/19
|
5/28/20
|
5/28/21
|
5/27/22
|
5/25/23
|
5/29/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
2,227
|
1,910
|
1,983
|
2,104
|
2,570
|
2,749
|
EBITDA
1 |
219.4
|
180.2
|
217.7
|
225.4
|
238.4
|
283.9
|
EBIT
1 |
182.3
|
142.3
|
172.9
|
172.8
|
181.1
|
225.5
|
Operating Margin
|
8.19%
|
7.45%
|
8.72%
|
8.22%
|
7.05%
|
8.21%
|
Earnings before Tax (EBT)
1 |
151.3
|
113.3
|
125.7
|
142.3
|
142
|
164.1
|
Net income
1 |
104.1
|
71.68
|
87.41
|
86.58
|
124.1
|
119.6
|
Net margin
|
4.68%
|
3.75%
|
4.41%
|
4.12%
|
4.83%
|
4.35%
|
EPS
2 |
4.110
|
2.860
|
3.530
|
3.470
|
4.970
|
4.780
|
Free Cash Flow
1 |
151.2
|
-16.49
|
95.64
|
-70.21
|
-69.2
|
-156.1
|
FCF margin
|
6.79%
|
-0.86%
|
4.82%
|
-3.34%
|
-2.69%
|
-5.68%
|
FCF Conversion (EBITDA)
|
68.93%
|
-
|
43.94%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
145.26%
|
-
|
109.42%
|
-
|
-
|
-
|
Dividend per Share
2 |
3.000
|
3.040
|
3.080
|
3.120
|
3.160
|
3.200
|
Announcement Date
|
5/24/19
|
5/28/20
|
5/28/21
|
5/27/22
|
5/25/23
|
5/29/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
125
|
412
|
476
|
661
|
788
|
1,009
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.5696
x
|
2.287
x
|
2.185
x
|
2.931
x
|
3.305
x
|
3.553
x
|
Free Cash Flow
1 |
151
|
-16.5
|
95.6
|
-70.2
|
-69.2
|
-156
|
ROE (net income / shareholders' equity)
|
7.97%
|
5.84%
|
7.3%
|
7.58%
|
9.23%
|
9.12%
|
ROA (Net income/ Total Assets)
|
5.3%
|
4.18%
|
4.84%
|
4.38%
|
4.33%
|
5.06%
|
Assets
1 |
1,966
|
1,715
|
1,805
|
1,975
|
2,864
|
2,366
|
Book Value Per Share
2 |
53.50
|
51.00
|
53.30
|
54.60
|
56.90
|
58.50
|
Cash Flow per Share
2 |
11.90
|
4.400
|
8.040
|
3.330
|
2.630
|
2.260
|
Capex
1 |
38.8
|
35.2
|
66.2
|
53.2
|
54.7
|
66
|
Capex / Sales
|
1.74%
|
1.84%
|
3.34%
|
2.53%
|
2.13%
|
2.4%
|
Announcement Date
|
5/24/19
|
5/28/20
|
5/28/21
|
5/27/22
|
5/25/23
|
5/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -30.46% | 1.16B | | +9.92% | 161B | | +9.60% | 21.5B | | +30.77% | 6.68B | | +84.64% | 2.39B | | -4.48% | 1.8B | | -6.43% | 1.67B | | 0.00% | 649M | | +18.62% | 558M | | -24.70% | 404M |
Other Tobacco
|